OCUPHIRE PHARMA INC (OCUP) Stock Analyst Ratings
USA - NASDAQ:OCUP - US67577R1023 - Common Stock
1.17 USD
-0.16 (-12.03%)
1.1601 USD
-0.01 (-0.85%)
ChartMill assigns a Buy % Consensus number of 82% to OCUP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.09. This target is 1360.26% above the current price.
OCUP was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about OCUP.
In the previous month the buy percentage consensus was at a similar level.
OCUP was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-20 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-03-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-26 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-24 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-05 | Alliance Global Partners | Initiate | Buy |
| 2021-03-29 | JonesTrading | Initiate | Buy |
| 2021-03-15 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-02-10 | Canaccord Genuity | Initiate | Buy |
OCUPHIRE PHARMA INC / OCUP FAQ
What is the average price target for OCUPHIRE PHARMA INC (OCUP) stock?
9 analysts have analysed OCUP and the average price target is 17.09 USD. This implies a price increase of 1360.26% is expected in the next year compared to the current price of 1.17.
Can you provide the consensus rating for OCUPHIRE PHARMA INC stock?
The consensus rating for OCUPHIRE PHARMA INC (OCUP) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for OCUPHIRE PHARMA INC stock?
The number of analysts covering OCUPHIRE PHARMA INC (OCUP) is 9.